Literature DB >> 2730116

Megakaryocytopoiesis in the human fetus.

J L Allen Graeve1, P A de Alarcon.   

Abstract

After immunohistochemical staining the size and maturational stage of fetal megakaryocytes from 20 human fetuses of 12 to 21 weeks' gestation were compared with those from normal adults. The mean diameter of fetal megakaryocytes was 14.0 microns when stained with antiglycoprotein IIb (Tab) and 15.2 microns when stained with antifactor VIII, which was significantly smaller than adult megakaryocytes, which were 18.4 microns when stained with Tab and 20.6 microns when stained with factor VIII. The proportion of immature (stage II) cells was higher--and the proportion of mature (stage IV) cells was lower--in the fetal tissue than in the adult. The smaller size and shift to a less mature population indicated that there were differences at the non-mitotic phase of the development of megakaryocytes in the fetus. Such differences were probably associated with quantitative and qualitative platelet abnormalities in newborn infants. Understanding the physiology and regulation of megakaryocytopoiesis in fetuses and newborn infants will be invaluable in determining the pathophysiology of platelet dysfunction in the newborn.

Entities:  

Mesh:

Year:  1989        PMID: 2730116      PMCID: PMC1592041          DOI: 10.1136/adc.64.4_spec_no.481

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

Review 1.  Control of platelet production.

Authors:  L A Harker
Journal:  Annu Rev Med       Date:  1974       Impact factor: 13.739

2.  [Platelet aggregation in the newborn infant].

Authors:  O Hrodek
Journal:  Nouv Rev Fr Hematol       Date:  1969 Jul-Aug

3.  The size of megakaryocytes in human fetal, infantile and adult hematopoiesis.

Authors:  T Izumi; M Kawakami; H Enzan; T Ohkita
Journal:  Hiroshima J Med Sci       Date:  1983-09

Review 4.  Biology of megakaryocytes.

Authors:  S Ebbe
Journal:  Prog Hemost Thromb       Date:  1976

5.  The relation of megakaryocyte ploidy to platelet volume.

Authors:  J D Bessman
Journal:  Am J Hematol       Date:  1984-02       Impact factor: 10.047

6.  The significance of megakaryocyte size.

Authors:  R F Levine; K C Hazzard; J D Lamberg
Journal:  Blood       Date:  1982-11       Impact factor: 22.113

7.  111In-oxine platelet survivals in thrombocytopenic infants.

Authors:  V Castle; G Coates; J G Kelton; M Andrew
Journal:  Blood       Date:  1987-09       Impact factor: 22.113

8.  Effect of prenatal drug administration on maternal and neonatal platelet aggregation and PF4 release.

Authors:  J M Whaun; G R Smith; V A Sochor
Journal:  Haemostasis       Date:  1980

9.  Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique.

Authors:  R F Levine; M E Fedorko
Journal:  J Cell Biol       Date:  1976-04       Impact factor: 10.539

10.  Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes.

Authors:  E M Rabellino; R B Levene; L L Leung; R L Nachman
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

View more
  9 in total

1.  Differences between newborn and adult mice in their response to immune thrombocytopenia.

Authors:  Zhongbo Hu; William B Slayton; Lisa M Rimsza; Matthew Bailey; Hannes Sallmon; Martha C Sola-Visner
Journal:  Neonatology       Date:  2010-02-04       Impact factor: 4.035

2.  Neonatal expression of RNA-binding protein IGF2BP3 regulates the human fetal-adult megakaryocyte transition.

Authors:  Kamaleldin E Elagib; Chih-Huan Lu; Goar Mosoyan; Shadi Khalil; Ewelina Zasadzińska; Daniel R Foltz; Peter Balogh; Alejandro A Gru; Deborah A Fuchs; Lisa M Rimsza; Els Verhoeyen; Miriam Sansó; Robert P Fisher; Camelia Iancu-Rubin; Adam N Goldfarb
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

Review 3.  Neonatal thrombocytopenia and megakaryocytopoiesis.

Authors:  Francisca Ferrer-Marin; Zhi-Jian Liu; Ravi Gutti; Martha Sola-Visner
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

Review 4.  Megakaryocyte ontogeny: Clinical and molecular significance.

Authors:  Kamaleldin E Elagib; Ashton T Brock; Adam N Goldfarb
Journal:  Exp Hematol       Date:  2018-03-02       Impact factor: 3.084

Review 5.  Modeling genetic platelet disorders with human pluripotent stem cells: mega-progress but wanting more on our plate(let).

Authors:  Catriana C Nations; Giulia Pavani; Deborah L French; Paul Gadue
Journal:  Curr Opin Hematol       Date:  2021-09-01       Impact factor: 3.218

Review 6.  Changes in megakaryopoiesis over ontogeny and their implications in health and disease.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Platelets       Date:  2020-03-21       Impact factor: 3.862

7.  Fetal vs adult megakaryopoiesis.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

Review 8.  The heterogeneity of megakaryocytes and platelets and implications for ex vivo platelet generation.

Authors:  Cuicui Liu; Baiming Huang; Hongtao Wang; Jiaxi Zhou
Journal:  Stem Cells Transl Med       Date:  2021-09-18       Impact factor: 6.940

Review 9.  Developmental changes in hematopoietic stem cell properties.

Authors:  Michael R Copley; Connie J Eaves
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.